Newsletter | July 8, 2026

07.08.26 -- Considerations For Scaling Downstream Viral Vector Manufacturing

SPONSOR

AAPS PharmSci 360

AAPS PharmSci 360 delivers research from across the drug development pipeline. Thousands of scientists from across the globe will converge October 25-28 in New Orleans to discuss cutting-edge breakthroughs at this science-first event. Learn more

FOCUS ON FILL-FINISH

Biophysical Tools For Biotherapeutic Development

Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.

FILL-FINISH SOLUTIONS

Streamline Your Path To Clinical Fill - West Pharmaceutical Services, Inc.

Single-Use Disposable Containers For Bulk Lyophilization - W.L. Gore & Associates

FOCUS ON DOWNSTREAM MANUFACTURING

Considerations For Scaling Downstream Viral Vector Manufacturing

In this segment from the Bioprocess Online Live event, "Downstream Decisions To Maximize Viral Vector Yields And Reduce COGs," panelists Hung Trinh, Ph.D., and Nathalie Clément, Ph.D., advise our audience on when to think about scaling a process and discuss which unit operations are most difficult to scale.

A New Specialist For Oligonucleotides With Advantages

Read about how hybrid silica technologies ensure stability and high resolution in IP-RP chromatography applications while protecting instrumentation from excessive wear and tear.

Considerations For Buffer Preparation As You Grow

Buffer preparation strategies impact cost, efficiency, and risk. Delve into the differences of in-house vs. outsourced approaches and how they help teams align supply decisions with operational needs.

Overcoming Challenges In Next-Generation Antibody Development

Unlock expert strategies for navigating the complex downstream purification and process challenges inherent in developing next-generation antibodies. Design for scalability from the start.

Overcoming Barriers To Adopting Membrane Technology

Examine results from a study demonstrating comparability in chromatographic process characteristics between a Protein A affinity capture membrane and a packed-bed resin reference.

DOWNSTREAM MANUFACTURING SOLUTIONS

Be A Gain Changer With 2x Throughput - Cytiva

Swiftly And Accurately Assess The Amount Of Protein Impurity - Cygnus Technologies Inc.

Enhancing Pharmacokinetic Predictability With FcRn Affinity Tools - Roche CustomBiotech

Connect With Bioprocess Online: